Globalization and Access to Drugs. Perspectives on the WTO/TRIPS Agreement - Health Economics and Drugs Series, No. 007 (Revised)
(1998; 97 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentAcknowledgements
View the documentAbbreviations and acronyms
Close this folderPART I: GLOBALIZATION AND ACCESS TO DRUGS: IMPLICATIONS OF THE WTO/TRIPS AGREEMENT
View the documentExecutive summary
View the documentIntroduction
Close this folder1. Brief historical background to the international trading system
View the document1.1 The simultaneous creation of the GATT, the IMF and the World Bank
Close this folder1.2 The objectives, nature and functioning of the GATT
View the documentObjectives
View the documentNature
View the documentObligations of the contracting parties
View the documentThe “Rounds”
Open this folder and view contents1.3 The Uruguay Round and the creation of the WTO
View the document1.4 The protection of intellectual property rights before the WTO
Open this folder and view contents2. Reading the TRIPS Agreement from the perspective of access to drugs
Open this folder and view contents3. Conclusions: issues at stake and constraints on access to drugs
View the documentDefinitions and terminology4
Open this folder and view contentsSelected bibliography5
Open this folder and view contentsPART II: PRESENTATIONS AT THE AD HOC WORKING GROUP ON THE REVISED DRUG STRATEGY HELD IN GENEVA ON 13 OCTOBER 1998
View the documentOther documents in the DAP - Health Economics and Drugs Series
View the documentBack cover
 
Objectives

The objectives of the GATT are clearly stated: they are to conclude “reciprocal and mutually advantageous arrangements” with a view to reducing customs duties and other barriers to trade and eliminating all discrimination in international trade.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: June 25, 2014